Abstract
US demand to grow 6% annually through 2012
US demand for enzymes will rise nearly six percent per year to $2.5 billion in
2012. Advances will be led by continued rapid expansion in the fuel ethanol
enzyme market, as well as strong growth in the large pharmaceutical and
smaller biocatalyst and pulp and paper markets. Healthy gains will also be
realized in diagnostics, research and biotechnology, and cosmetics and
toiletries, although this will be offset somewhat by maturity in food and
beverages, animal feed and cleaning products applications.
Growth in the US enzyme industry will be dominated by the rapid expansion of
the fuel ethanol industry, as ethanol producers strive to meet the country' s
renewable fuel needs specified in the Energy Independence and Security Act of
2007. Even as the country reaches a practical limit on how much corn it can
convert into ethanol, the rise of second generation, cellulosic biomass
ethanol production will continue to drive rapid enzyme demand growth over the
longer term.
Pharmaceuticals will remain dominant market
Pharmaceuticals, which will remain the largest enzyme market going forward,
will also achieve above average growth. Advances will stem from continuing
strong demand for neuromodulators and orphan drug enzymes for treating
lysosomal storage disorders. Fast expansion in smaller pharmaceutical
applications such as cancer treatment and wound debridement will also support
gains.
Study coverage
It presents historical demand data plus forecasts for 2012 and 2017 by market
and product. This study also assesses market environment factors, evaluates
company market share and profiles 39 competitors in the US industry.
View Cart
